Association for Molecular Pathology v. Myriad Genetics
GPTKB entity
Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:court_cases
|
| gptkbp:case_outcome |
unanimous decision
|
| gptkbp:consequences |
influenced patent law
influenced future litigation influenced academic research increased access to genetic testing affected commercialization of genetic tests affected genetic research affected patent applications affected the development of genetic therapies changed patenting practices changed the approach to genetic research funding changed the landscape of biotechnology patents changed the public perception of gene patents encouraged collaboration in genetic research encouraged ethical considerations in genetics encouraged open science encouraged transparency in genetic research increased awareness of genetic issues increased scrutiny of gene patents influenced international patent law influenced the commercialization of biotechnology. influenced the ethics of genetic research influenced the role of universities in patenting led to increased litigation over gene patents led to new legislation on genetic patents promoted innovation in genetics promoted patient advocacy in genetics redefined intellectual property rights reduced barriers to research shaped public policy on genetics shaped the future of genetic counseling sparked debates on genetic ownership |
| gptkbp:decided_by |
gptkb:Supreme_Court_of_the_United_States
|
| gptkbp:dissenting_opinion |
gptkb:Justice_Thomas
gptkb:Justice_Scalia |
| gptkbp:economic_impact |
healthcare industry
biotechnology industry |
| gptkbp:effective_date |
June 13, 2013
|
| https://www.w3.org/2000/01/rdf-schema#label |
Association for Molecular Pathology v. Myriad Genetics
|
| gptkbp:involved_parties |
gptkb:Myriad_Genetics
gptkb:Association_for_Molecular_Pathology |
| gptkbp:is_cited_in |
569 U. S. 576 (2013)
|
| gptkbp:is_standardized_by |
gptkb:natural_wonder
laws of nature abstract ideas |
| gptkbp:legal_issue |
patentability of human genes
|
| gptkbp:outcome |
invalidated patents on isolated DNA
|
| gptkbp:precedent |
set precedent for gene patenting
|
| gptkbp:public_perception |
gptkb:Justice_Sotomayor
gptkb:Justice_Kagan gptkb:Justice_Ginsburg gptkb:Justice_Breyer |
| gptkbp:related_cases |
gptkb:Mayo_Collaborative_Services_v._Prometheus_Laboratories
gptkb:Bilski_v._Kappos |
| gptkbp:significance |
impact on genetic testing
|
| gptkbp:bfsParent |
gptkb:BRCA2
|
| gptkbp:bfsLayer |
5
|